Clinical Trials Directory

Trials / Completed

CompletedNCT05627076

Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

Comparison of PSP Values Measured With Venous Whole Blood and Those Measured With Arterial Whole Blood.

Status
Completed
Phase
Study type
Observational
Enrollment
46 (actual)
Sponsor
Abionic SA · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Abionic has developed a targeted, rapid test for pancreatic stone protein (PSP) in human K2-EDTA venous whole blood using the abioSCOPE instrument. Currently no PSP study comparaison has been done between venous and arterial whole blood. Abionic would like to confirm the equivalence of the PSP between venous whole blood and arterial whole blood.

Conditions

Interventions

TypeNameDescription
DEVICEBlood SamplingBlood samples will be collected for the PSP measurement using the abioSCOPE.

Timeline

Start date
2022-08-29
Primary completion
2022-10-11
Completion
2022-10-31
First posted
2022-11-25
Last updated
2022-11-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05627076. Inclusion in this directory is not an endorsement.

Analytical Validation of the abioSCOPE Device With the IVD CAPSULE PSP Test: Comparison of PSP Values Measured With Veno (NCT05627076) · Clinical Trials Directory